These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 22643762)

  • 1. Should direct-to-consumer personalized genomic medicine remain unregulated?: a rebuttal of the defenses.
    Valles SA
    Perspect Biol Med; 2012; 55(2):250-65. PubMed ID: 22643762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic gatekeepers: regulating direct-to-consumer genomic services in an era of participatory medicine.
    Palmer JE
    Food Drug Law J; 2012; 67(4):475-524, iii. PubMed ID: 24640618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct-to-consumer genetic testing: good, bad or benign?
    Caulfield T; Ries NM; Ray PN; Shuman C; Wilson B
    Clin Genet; 2010 Feb; 77(2):101-5. PubMed ID: 19968666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FDA to regulate direct-to-consumer genetic tests.
    Brower V
    J Natl Cancer Inst; 2010 Nov; 102(21):1610-2, 1617. PubMed ID: 20966430
    [No Abstract]   [Full Text] [Related]  

  • 5. Personalized medicine - the promised land: are we there yet?
    Li C
    Clin Genet; 2011 May; 79(5):403-12. PubMed ID: 21204795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct-to-consumer genetic tests, government oversight, and the First Amendment: what the government can (and can't) do to protect the public's health.
    Javitt GH; Stanley E; Hudson K
    Oklahoma Law Rev; 2004; 57(2):251-302. PubMed ID: 15658034
    [No Abstract]   [Full Text] [Related]  

  • 7. Direct-to-consumer genetic testing: learning from the past and looking toward the future.
    Bair S
    Food Drug Law J; 2012; 67(4):413-33, ii. PubMed ID: 24640615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FDA halts 23andMe personal genetic tests. What might this mean for the future of direct-to-consumer testing?
    Darnovsky M; Cussins J
    MLO Med Lab Obs; 2014 Mar; 46(3):33. PubMed ID: 24696953
    [No Abstract]   [Full Text] [Related]  

  • 9. ACOG Committee Opinion No. 409: Direct-to-consumer marketing of genetic testing.
    ;
    Obstet Gynecol; 2008 Jun; 111(6):1493-4. PubMed ID: 18515540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bridging the consumer-medical divide: how to regulate direct-to-consumer genetic testing.
    Edwards KT; Huang CJ
    Hastings Cent Rep; 2014; 44(3):17-9. PubMed ID: 24821248
    [No Abstract]   [Full Text] [Related]  

  • 11. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2397-406. PubMed ID: 12692171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Science and regulation. Regulating direct-to-consumer personal genome testing.
    McGuire AL; Evans BJ; Caulfield T; Burke W
    Science; 2010 Oct; 330(6001):181-2. PubMed ID: 20929761
    [No Abstract]   [Full Text] [Related]  

  • 13. [The real « personal genome » ?].
    Jordan B
    Med Sci (Paris); 2011 May; 27(5):553-6. PubMed ID: 21609679
    [No Abstract]   [Full Text] [Related]  

  • 14. How do pharmaceutical companies handle consumer adverse drug reaction reports? An overview based on a survey of French drug safety managers and officers.
    Fleuranceau-Morel P
    Pharmacoepidemiol Drug Saf; 2002; 11(1):37-44. PubMed ID: 11998550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Direct-to-consumer genetic testing through Internet: marketing, ethical and social issues].
    Ducournau P; Gourraud PA; Rial-Sebbag E; Bulle A; Cambon-Thomsen A
    Med Sci (Paris); 2011 Jan; 27(1):95-102. PubMed ID: 21299969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genome technologies and personalized dental medicine.
    Eng G; Chen A; Vess T; Ginsburg GS
    Oral Dis; 2012 Apr; 18(3):223-35. PubMed ID: 22129463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multigene classifiers, prognostic factors, and predictors of breast cancer clinical outcome.
    Ross JS
    Adv Anat Pathol; 2009 Jul; 16(4):204-15. PubMed ID: 19546609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Direct to consumer genetic testing: is it the moment?].
    Lamoril J; Bogard M
    Ann Biol Clin (Paris); 2016; 74(1):29-54. PubMed ID: 26743633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct-to-Consumer Genetic Testing and Orphan Drug Development.
    Mason M; Levenson J; Quillin J
    Genet Test Mol Biomarkers; 2017 Aug; 21(8):456-463. PubMed ID: 28696792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Europe to ban direct-to-consumer genetic tests?
    Borry P
    Nat Biotechnol; 2008 Jul; 26(7):736-7. PubMed ID: 18612288
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.